Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
MALIGNANT HYPERTHERMIA GATEWAY SURGERY CENTER This program about Malignant Hyperthermia will review: Definition Etiology and Pathogenesis Clinical Picture and Diagnosis Therapy Prevention Imposters Malignant Hyperthermia A chain reaction event (syndrome) triggered in susceptible individuals by commonly used anesthetics An autosomal-dominant disorder Life threatening Causes of Malignant Hyperthermia Triggering agents release calcium for storage sites in muscles leading to elevated calcium concentrations in the muscles High calcium levels increase metabolism causing the muscles to contract and become rigid The process results in heat production, acidosis and muscle cell breakdown Triggers of Malignant Hyperthermia Volatile inhalation agents Succinylcholine Clinical Picture of MH Masseter spasms Tachycardia Increased end tidal CO2 Hypoxemia Flushing of the skin Hypotension Metabolism acidosis Hyperthermia Body rigidity Treatment of MH Stop triggering agents 100% Oxygen Stop surgery ASAP Deepen anesthesia with opiods, sedatives and relaxation with non depolarizing relaxant Dantrolene 2.5 mg/kg bolus IV, repeat until hypermetabolism stops. May need more than Dantrolene 10 mg/kg. Give 1 mg/kg every 6 hours after control of the episode for 24 hours. Sodium Bicarb according to ABG Treatment of MH continued… Antiarrhythmic therapy with beta blocker or lidocaine Cooling measures Additional monitors…A-line, CVP, urinary catheter Force diuresis Check renal function, coagulation, electrolytes, creatin kinase and temperature Inform patient and relatives…Test for MH Test for Malignant Hyperthermia No simple test available for screening Requires skeletal muscle biopsy from thigh Perform caffeine halothane contracture test Prevention of MH Pre-op visit -- family history Good anxiolysis Monitors…EKG, CO2, SaO2 Dantrolene Persistent elevated creatin kinase Avoid triggering agents…flush anesthesia machine with O2 10 liters/min for 20 minutes…change soda lime MH patients in the ASC? Yes, use non-triggering agents Observe for 3-5 hours Imposter: Sudden Unexpected Cardiac Arrest Sudden Unexpected Cardiac Arrest occurs in young males soon after succinylcholine usually with an undiagnosed myopathy. Measure potassium ASAP and treat with calcium, hyperventilation, glucose and insulin Imposter: Neuroleptic Malignant Syndrome Neuroleptic Malignant Syndrome is reported in patients that receive neuroleptics for a range of psychiatric illnesses as well as medical patients who receive neuroleptics as antiemetics or sedatives. Clinical characteristics include rigidity, mental status changes and hyperthermia NMS is a self-limiting disorder when the neuroleptics are withdrawn. Recovery time has been estimated at 7-10 days.